Alvotech (ALVO) Net Margin (2022 - 2026)

Alvotech (ALVO) posted Net Margin of 2.01% for Q1 2026, down 99.29% on a QoQ basis from 282.03% in Q4 2025, and down 9778.0% year-over-year from 0.02% in Q1 2025.

Alvotech (ALVO) Net Margin (2022 - 2026) Analysis & Trends

Alvotech's Net Margin history runs 5 years deep, the most recent figure standing at 2.01% for Q1 2026.

  • Quarterly Net Margin fell 9778.0% year-over-year to 2.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 75.9% (down 7812.0% YoY) and the FY2025 annual result came in at 39.7%, up 12997.0% from the prior year.
  • Net Margin was 2.01% for Q1 2026 at Alvotech, down from 282.03% in the prior quarter.
  • Across five years, Net Margin topped out at 7606.06% in Q2 2022 and bottomed at 13031.86% in Q1 2022.
  • A 5-year average of 943.41% and a median of 0.87% in 2023 frame the typical range for Net Margin.
  • Peak annual rise in Net Margin reached 1303186 bps in 2023, while the deepest fall reached 760694 bps in 2023.
  • Alvotech's Net Margin stood at 3924.83% in 2022, then grew by 12 bps to 3445.34% in 2023, then soared by 90 bps to 338.91% in 2024, then jumped by 183 bps to 282.03% in 2025, then tumbled by 99 bps to 2.01% in 2026.
  • Business Quant data shows ALVO's Net Margin at 2.01% in Q1 2026, 282.03% in Q4 2025, and 942.96% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn 2.01%

Historic Data

Download Data
DateValue
Mar 31, 2026 2.01%
Dec 31, 2025 282.03%
Sep 30, 2025 -942.96%
Jun 30, 2025 33.79%
Mar 31, 2025 99.79%
Dec 31, 2024 -338.91%
Sep 30, 2024 -488.80%
Jun 30, 2024 -1.20%
Mar 31, 2024 0.00%
Dec 31, 2023 -3,445.34%
Jun 30, 2023 -0.87%
Mar 31, 2023 0.00%
Dec 31, 2022 -3,924.83%
Jun 30, 2022 7,606.06%
Mar 31, 2022 -13,031.86%